Pharmaceuticals in Russia

Date: December 11, 2015
Pages: 39
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PE5AB30CEE9EN
Leaflet:

Download PDF Leaflet

INTRODUCTION

Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Russia pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

HIGHLIGHTS
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2014 annual average exchange rates.
  • The Russian pharmaceuticals market had total revenues of $20.0bn in 2014, representing a compound annual growth rate (CAGR) of 17% between 2010 and 2014.
  • The Russian pharmaceutical market is experiencing high growth at the time being and is expected to enter the top ten of pharmaceuticals spending countries within three years.
  • The performance of the market is forecast to decelerate, with an anticipated CAGR of 11.2% for the five-year period 2014 - 2019, which is expected to drive the market to a value of $34.1bn by the end of 2019.
FEATURES
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Russia
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Russia
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Russia pharmaceuticals market with five year forecasts
  • Macroeconomic indicators provide insight into general trends within the Russia economy
KEY QUESTIONS ANSWERED
  • What was the size of the Russia pharmaceuticals market by value in 2014?
  • What will be the size of the Russia pharmaceuticals market in 2019?
  • What factors are affecting the strength of competition in the Russia pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in Russia's pharmaceuticals market?
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Bayer AG
Pfizer Inc.
Pharmstandard OJSC
Sanofi SA
Macroeconomic Indicators
Country Data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

List of Tables

Table: Russia pharmaceuticals market value: $ billion
Table: Russia pharmaceuticals market geography segmentation: $ billion,
Table: Russia pharmaceuticals market share: % share, by value,
Table: Russia pharmaceuticals market value forecast: $ billion
Table: Bayer AG: key facts
Table: Bayer AG: key financials ($)
Table: Bayer AG: key financials (€)
Table: Bayer AG: key financial ratios
Table: Pfizer Inc.: key facts
Table: Pfizer Inc.: key financials ($)
Table: Pfizer Inc.: key financial ratios
Table: Pharmstandard OJSC: key facts
Table: Pharmstandard OJSC: key financials ($)
Table: Pharmstandard OJSC: key financials (RUB)
Table: Pharmstandard OJSC: key financial ratios
Table: Sanofi SA: key facts
Table: Sanofi SA: key financials ($)
Table: Sanofi SA: key financials (€)
Table: Sanofi SA: key financial ratios
Table: Russia size of population (million)
Table: Russia gdp (constant prices, $ billion)
Table: Russia gdp (current prices, $ billion)
Table: Russia inflation
Table: Russia consumer price index (absolute)
Table: Russia exchange rate

List of Figures

Figure: Russia pharmaceuticals market value: $ billion
Figure: Russia pharmaceuticals market geography segmentation: % share, by value,
Figure: Russia pharmaceuticals market share: % share, by value,
Figure: Russia pharmaceuticals market value forecast: $ billion
Figure: Forces driving competition in the pharmaceuticals market in Russia,
Figure: Drivers of buyer power in the pharmaceuticals market in Russia,
Figure: Drivers of supplier power in the pharmaceuticals market in Russia,
Figure: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia,
Figure: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia,
Figure: Drivers of degree of rivalry in the pharmaceuticals market in Russia,
Figure: Bayer AG: revenues & profitability
Figure: Bayer AG: assets & liabilities
Figure: Pfizer Inc.: revenues & profitability
Figure: Pfizer Inc.: assets & liabilities
Figure: Pharmstandard OJSC: revenues & profitability
Figure: Pharmstandard OJSC: assets & liabilities
Figure: Sanofi SA: revenues & profitability
Figure: Sanofi SA: assets & liabilities
Skip to top


OTC Pharmaceuticals in Russia US$ 350.00 Sep, 2015 · 39 pages
The Pharmaceutical Market: Russia US$ 1,295.00 Jan, 2013 · 97 pages

Ask Your Question

Pharmaceuticals in Russia
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: